Basic Information
ID: ALA5163692
Type: Binding
Description: Inhibition of human cytomegalovirus pHAR-UL89C expressed in Escherichia coli Rosette using Digoxigenin-labeled 5'-taatcgccttgcagcacatccccattcgccagctggcgtaatagcgaagaggcccgca ssDNA as substrate at 5 uM preincubated for 15 mins followed by substrate addition for 30 mins by plate reader assay relative to control
Organism: Cytomegalovirus
Activity Charts
Bioactivity
Activity Types for Assay ALA5163692
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 238.22 | 1.31 | 1.31 |
| 232.19 | 1.25 | 1.25 |
| 252.25 | 1.40 | 1.40 |
| 246.22 | 1.18 | 1.18 |
| 252.25 | 1.62 | 1.62 |
| 327.37 | 2.55 | 2.55 |
| 345.36 | 2.69 | 2.69 |
| 277.25 | 0.85 | 0.85 |
| 313.34 | 2.87 | 2.87 |
| 341.39 | 2.85 | 2.85 |
| 361.81 | 3.20 | 3.20 |
| 315.11 | 2.48 | 2.48 |
| 260.25 | 1.27 | 1.27 |
| 238.22 | 1.31 | 1.31 |
| 264.21 | 0.90 | 0.90 |
| 246.22 | 0.93 | 0.93 |
| 170.12 | -0.52 | -0.52 |
| 280.67 | 1.83 | 1.83 |
| 294.69 | 1.51 | 1.51 |
| 264.21 | 1.07 | 1.07 |
| 349.39 | 2.30 | 2.30 |
| 266.28 | 0.91 | 0.91 |
| 296.23 | 1.13 | 1.13 |
| 184.15 | -0.43 | -0.43 |
| 252.25 | 0.83 | 0.83 |
| 278.24 | 0.99 | 0.99 |
| 273.29 | 1.02 | 1.02 |
| 329.14 | 2.16 | 2.16 |
| 260.25 | 1.07 | 1.07 |
| 329.14 | 2.16 | 2.16 |
| 250.19 | 0.98 | 0.98 |
| 259.26 | 0.71 | 0.71 |
| 236.18 | 0.52 | 0.52 |
| 295.24 | 0.99 | 0.99 |
| 328.15 | 2.02 | 2.02 |
| 390.23 | 3.38 | 3.38 |
| 308.29 | 2.51 | 2.51 |
| 252.25 | 0.99 | 0.99 |
| 396.25 | 3.44 | 3.44 |
| 363.35 | 2.41 | 2.41 |
| 327.26 | 1.73 | 1.73 |
| 276.25 | 0.56 | 0.56 |
| 266.28 | 1.30 | 1.30 |
| 266.28 | 0.91 | 0.91 |
| 363.35 | 2.41 | 2.41 |
| 404.25 | 3.30 | 3.30 |
| 282.20 | 1.04 | 1.04 |
| 395.36 | 3.15 | 3.15 |
| 315.11 | 2.07 | 2.07 |
| 252.25 | 0.83 | 0.83 |
| 296.23 | 1.13 | 1.13 |
| 322.32 | 2.60 | 2.60 |
| 289.29 | 0.72 | 0.72 |
| 335.36 | 2.38 | 2.38 |
| 262.22 | 0.47 | 0.47 |
| 274.28 | 1.16 | 1.16 |
| 282.20 | 1.04 | 1.04 |